179 related articles for article (PubMed ID: 3032852)
1. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen.
Nielsen VG; Webster RO
Immunopharmacology; 1987 Feb; 13(1):61-71. PubMed ID: 3032852
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
Webster RO; Goldstein IM; Flick MR
J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
[TBL] [Abstract][Full Text] [Related]
3. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
Farmer JC; Burkey TH; Kew RR; Webster RO
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of some human neutrophil functions by the cyclooxygenase inhibitor ketorolac tromethamine.
Hyers TM; Tricomi SM; Liao JJ
J Leukoc Biol; 1992 May; 51(5):490-5. PubMed ID: 1318350
[TBL] [Abstract][Full Text] [Related]
6. Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.
Bajaj MS; Kew RR; Webster RO; Hyers TM
Inflammation; 1992 Jun; 16(3):241-50. PubMed ID: 1323530
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
Schröder JM; Kosfeld U; Christophers E
J Invest Dermatol; 1985 Jul; 85(1):30-4. PubMed ID: 2989375
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation.
Kocan GP; Partis RA; Mueller RA; Smith WG; Nakao A
Biochem Pharmacol; 1994 Mar; 47(6):1029-37. PubMed ID: 8147901
[TBL] [Abstract][Full Text] [Related]
9. Selective regulation of human neutrophil functions by the cell activation inhibitor CI-959.
Wright CD; Stewart SF; Kuipers PJ; Hoffman MD; Devall LJ; Kennedy JA; Ferin MA; Thueson DO; Conroy MC
J Leukoc Biol; 1994 Apr; 55(4):443-51. PubMed ID: 8145014
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of in vitro neutrophil responses to chemotactic factors by piroxicam.
Tanaka K; Kanaoka K; Egawa M; Abe N; Watanabe I; Hirai S
Jpn J Pharmacol; 1984 Jun; 35(2):181-91. PubMed ID: 6611436
[TBL] [Abstract][Full Text] [Related]
11. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo.
Kaplan HB; Edelson HS; Korchak HM; Given WP; Abramson S; Weissmann G
Biochem Pharmacol; 1984 Feb; 33(3):371-8. PubMed ID: 6422946
[TBL] [Abstract][Full Text] [Related]
12. Phorbol myristate acetate enhances human polymorphonuclear neutrophil release of granular enzymes but inhibits chemokinesis.
Hoult JR; Nourshargh S
Br J Pharmacol; 1985 Nov; 86(3):533-7. PubMed ID: 4063581
[TBL] [Abstract][Full Text] [Related]
13. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
14. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
Ward PA; Sulavik MC; Johnson KJ
Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
Tonnesen MG; Smedly LA; Henson PM
J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-922: differential inhibition of responses to a variety of stimuli.
Wright CD; Hoffman MD; Thueson DO; Conroy MC
J Leukoc Biol; 1987 Jul; 42(1):30-5. PubMed ID: 2439626
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229
[TBL] [Abstract][Full Text] [Related]
19. The effect of calcium antagonists on the activation of guinea pig neutrophils.
Azuma Y; Tokunaga T; Takeda Y; Ogawa T; Takagi N
Jpn J Pharmacol; 1986 Oct; 42(2):243-51. PubMed ID: 3025491
[TBL] [Abstract][Full Text] [Related]
20. Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.
Spilberg I; Mehta J; Muniain MA; Simchowitz L; Atkinson J
Inflammation; 1984 Mar; 8(1):73-86. PubMed ID: 6325345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
